Literature DB >> 21392875

Dexmedetomidine sedation for awake fiberoptic intubation of patients with difficult airways due to severe odontogenic cervicofacial infections.

Barry C Boyd1, Steven J Sutter.   

Abstract

PURPOSE: Odontogenic infections present challenging airway scenarios to surgeons and anesthesiologists. Among specialists, there is controversy over airway management for those patients with airways made difficult by trismus and swelling with anatomic impingement and derangement. Awake fiberoptic intubation has achieved favor in the oral and maxillofacial surgery and anesthesiology communities for management of such difficult airways, but patient comfort and anxiety management with traditional agents may prove hazardous because of potential suppression of protective mechanisms and respiratory depression. PATIENTS AND METHODS: Three cases are presented showing the utility and safety of the use of dexmedetomidine sedation for presurgical airway instrumentation and insertion in patients with challenging airways because of severe cervicofacial odontogenic infections.
RESULTS: Dexmedetomidine administration provided safe and effective sedation and anxiolysis for awake fiberoptic airway instrumentation and airway insertion in patients presenting with severe cervicofacial infections with difficult airways because of anatomic obstruction.
CONCLUSIONS: Dexmedetomidine sedation is advocated for use in awake fiberoptic intubation of patients with cervicofacial infections and difficult airways because of its ability to provide sedation, analgesia, reversible anterograde amnesia, and anxiolysis without impairment of protective reflexes, respiratory depression, or hemodynamic compromise. One of the most significant challenges facing oral and maxillofacial surgeons is the difficult airway. Anatomically compromised airways present unique clinically daunting situations to both surgeon and anesthesiologist, who are both charged with the provision of safe, effective preoperative, intraoperative, and postoperative airway management. Among these conditions, odontogenic infections and patients with head and neck trauma, temporomandibular disorders, orofacial tumors, and severe craniofacial anomalies present for surgical treatment by the oral and maxillofacial surgeon.
Copyright © 2011 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21392875     DOI: 10.1016/j.joms.2010.11.004

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  9 in total

Review 1.  Dexmedetomidine for the management of awake fibreoptic intubation.

Authors:  Xing-Ying He; Jian-Ping Cao; Qian He; Xue-Yin Shi
Journal:  Cochrane Database Syst Rev       Date:  2014-01-19

2.  Dexmedetomidine: New avenues.

Authors:  Anju Grewal
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2011-07

3.  Dexmedetomidine versus remifentanil for sedation during awake intubation using a Shikani optical stylet: a randomized, double-blinded, controlled trial.

Authors:  Ting Xu; Min Li; Cheng Ni; Xiang-Yang Guo
Journal:  BMC Anesthesiol       Date:  2016-08-02       Impact factor: 2.217

4.  Comparison of Intravenous Dexmedetomidine-Propofol Versus Ketofol for Sedation During Awake Fiberoptic Intubation: A Prospective, Randomized Study.

Authors:  Mona Blough El Mourad; Mona Raafat Elghamry; Radwa Fathy Mansour; Mohamed Elsayed Afandy
Journal:  Anesth Pain Med       Date:  2019-02-26

5.  Comparison between Intravenous Dexmedetomidine and Spray as you Go with 4% Lignocaine Versus Intravenous Fentanyl and Transtracheal Injection of 4% Lignocaine for Awake Nasotracheal Intubation with Flexible Vedioscope - A Randomized Single-Blind Prospective Study.

Authors:  Miriyala Pavan Kumar; Madhusmita Patro; Sasmita Panigrahy; Soumya Samal; B Sai Kartheek
Journal:  Anesth Essays Res       Date:  2021-12-16

6.  Comparative Evaluation of the Intranasal Spray Formulation of Midazolam and Dexmedetomidine in Patients Undergoing Surgical Removal of Impacted Mandibular Third Molars: A Split Mouth Prospective Study.

Authors:  Shashank Hiwarkar; Rajesh Kshirsagar; Vikram Singh; Amod Patankar; Sanjay Chandan; Mukund Rathod; Ajay Mohite
Journal:  J Maxillofac Oral Surg       Date:  2016-12-18

Review 7.  Dexmedetomidine: an adjuvant making large inroads into clinical practice.

Authors:  Sj Bajwa; A Kulshrestha
Journal:  Ann Med Health Sci Res       Date:  2013-10

8.  Nasotracheal fiberoptic intubation: patient comfort, intubating conditions and hemodynamic stability during conscious sedation with different doses of dexmedetomidine.

Authors:  Satish Chandra Dhasmana
Journal:  J Maxillofac Oral Surg       Date:  2013-01-18

9.  Comparision of Vital Surgical Parameters, after Administration of Midazolam and Dexmedetomidine for Conscious Sedation in Minor Oral Surgery.

Authors:  Suryahanthmihiran Sivasubramani; Deepak Abraham Pandyan; C Ravindran
Journal:  Ann Maxillofac Surg       Date:  2019 Jul-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.